Convergent Dental, Inc., developers of Solea®, the industry-leading CO2 all-tissue dental laser system, is pleased to announce two new appointments to its executive leadership team. Daryl Donatelli recently joined the Company as Vice President of Marketing, and Charles Kerbage now holds the title of Vice President of Research and Development.
In his new role as Vice President of Marketing, Daryl Donatelli will drive all marketing efforts for Convergent Dental’s flagship product Solea, the #1 selling dental laser for hard, soft, and osseous tissue procedures. Donatelli will lead Convergent Dental’s marketing team efforts including product strategy, marketing communications, business partnerships, and sales enablement.
“I’m very excited to be part of creating what will definitely be a new standard of care for dentistry,” remarked Donatelli. “I am even more excited about enabling an experience for patients that will forever change what it means to go to the dentist.”
Donatelli brings over fifteen years of executive marketing experience to Convergent Dental, including the commercialization and growth of major medical devices and consumer health portfolios across North America, Asia, and Europe.
Donatelli holds a BA in Economics from the University of Rochester, and an MBA from Simon Business School.
Charles Kerbage has joined Convergent Dental as Vice President of Research and Development. Kerbage will lead the Company’s R&D team in identifying opportunities for innovation that will both improve existing product performance and bring new capabilities into the company’s product portfolio.
“Having come from the laser industry, I was attracted to the innovative culture and commitment to creating excellent products that exists at Convergent Dental,” remarked Kerbage. “The folks at Convergent are true pioneers in dental laser technology, and their reputation for a superior customer experience is second to none. I am thrilled to be working with such a high-powered and motivated team of professionals.”
A technical leader with strong business acumen, Kerbage has over fifteen years of experience in scientific and technological innovation and has transitioned numerous technical developments into game-changing solutions in the medical devices, life sciences, and photonics industries.
Kerbage holds a PhD in Applied Physics from Columbia University, and an MBA from Boston University.
For more information about Solea, please visit www.convergentdental.com or call 844.GOSOLEA.
About Convergent Dental, Inc.
Convergent Dental, Inc. is a privately owned dental equipment and technology company. Solea® is the only computer-aided, CO2 laser system to be cleared by the FDA for all tissue indications. With Solea’s unique wavelength and computer controls, dentists can reliably perform procedures anesthesia-free, blood-free, suture-free, and pain-free. Reliably anesthesia-free and blood-free procedures pay huge dividends for patients in the form of a vastly improved dental experience and dentists in terms of significant practice growth. For more information, please visit www.convergentdental.com. Follow the company on Twitter, Facebook and LinkedIn.